Search

everythinglearnresearchcommunity

for

Search:↓

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Probiotics significantly reduce the severity of atopic dermatitis.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Restoring hair follicle immune privilege may help treat alopecia areata.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

A new mouse model effectively mimics vitiligo for research and drug testing.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

NK cells play a role in skin diseases like eczema and psoriasis.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Type XVII collagen helps control skin cell growth and rejuvenates skin.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

TH07 is a topical combination of finasteride, latanoprost, and minoxidil, and shows promise.

Third-generation antihistamines are the safest and most effective for allergies.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

New compounds were made that are promising for prostate cancer therapy.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

New acne treatments like clascoterone and minocycline foam are effective, and using antibiotics carefully is important to avoid resistance.

Altering the keratin 17 gene in mice hair follicles caused temporary hair issues, but changes were minimal and short-lived.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.